About Source Molecular
Source Molecular is a company based in Miami (United States) founded in 2002 was acquired by LuminUltra in November 2020. Source Molecular has raised $1.62 million across 1 funding round from investors including LuminUltra and New World Angels. Source Molecular offers products and services including SMART qPCR Management Platform, SMART qPCR Reagents and Kits, and COVID-19 Testing Services. Source Molecular operates in a competitive market with competitors including AFYREN, Spore Biotechnologies, GBA Group, Biopsin and Mesosil, among others.
- Headquarter Miami, United States
-
Sectors
HealthcareEnvironment
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Source Molecular Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.62 M (USD)
in 1 rounds
-
Latest Funding Round
$1.62 M (USD), Series A
Jul 11, 2017
-
Investors
LuminUltra
& 1 more
-
Employee Count
Not available
-
Acquired by
LuminUltra
(Nov 30, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Source Molecular
Source Molecular offers a comprehensive portfolio of products and services, including SMART qPCR Management Platform, SMART qPCR Reagents and Kits, and COVID-19 Testing Services.
Platform for managing environmental qPCR tests.
Reagents for pathogen and DNA marker analysis.
Environmental testing for SARS-CoV-2 detection.
Funding Insights of Source Molecular
Source Molecular has successfully raised a total of $1.62M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.62 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Source Molecular
Source Molecular has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include LuminUltra and New World Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage funding and guidance are provided to Florida entrepreneurs.
|
Locked | Locked | Locked | |
|
Microbial concentrations in water are monitored via ATP luminometer technology.
|
Locked | Locked | Locked |
Investor details for Source Molecular
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Source Molecular
Investment portfolio details for Source Molecular
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Source Molecular
Detailed financials for Source Molecular
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Source Molecular Comparisons
Peer comparison for Source Molecular
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Source Molecular
Source Molecular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AFYREN, Spore Biotechnologies, GBA Group, Biopsin and Mesosil, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Analytical services are provided for microbiology, chemistry, and bioprocesses sectors.
|
|
| Locked | Locked | Locked |
Microbial detection technology is developed for life science industries.
|
|
| Locked | Locked | Locked |
GBA Group is recognized as a leading life sciences service provider.
|
|
| Locked | Locked | Locked |
Real-time microbial detection system is developed for product testing.
|
|
| Locked | Locked | Locked |
Antimicrobial materials are developed for infection prevention in medical devices.
|
|
| Locked | Locked | Locked |
Provider of analytical and quality testing services for drug development and diagnostics
|
Detailed competitors of Source Molecular
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Source Molecular
Complete news archive for Source Molecular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Source Molecular
Source Molecular was founded in 2002 and raised its 1st funding round 15 years after it was founded.
Source Molecular is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Source Molecular is a funded company, having raised a total of $1.62M across 1 funding round to date.
Source Molecular was founded in 2002 and is headquartered in Miami, United States. Technology focused on microbial source tracking is developed and supplied by the company, primarily within the biotechnology sector. Operations center on delivering tools for identifying and monitoring microbial origins in environmental samples. Services are extended to clients in water quality and public health fields, with the domain sourcemolecular.com used for online access.
Source Molecular's top competitors include AFYREN, Spore Biotechnologies and NCIMB.
Source Molecular offers SMART qPCR Management Platform, SMART qPCR Reagents and Kits, and COVID-19 Testing Services.
Source Molecular has 2 investors. Key investors include LuminUltra, and New World Angels.